产品封面图

IP12901 帕比司他(10mM in DMSO,无菌)

抑制剂/拮抗剂/激动剂 索莱宝
收藏
  • ¥640
  • Solarbio已认证
  • 北京
  • IP12901
  • 2025年07月23日
    avatar
    品牌商
    14钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Stroe at -20℃,6 months.

    • 保质期

      Stroe at -20℃,6 months.

    • 英文名

      Panobinostat(10mM in DMSO,Sterile)

    • 库存

      现询

    • 供应商

      北京索莱宝科技有限公司

    • CAS号

      404950-80-7

    • 规格

      1ml

    基本信息
    CASNo.404950-80-7
    中文名称帕比司他(10mM in DMSO,无菌)
    英文名称Panobinostat(10mM in DMSO,Sterile)
    分子式C21H23N3O2
    分子量349.43
    溶解性请根据自己的实验要求使用。
    外观(性状)无菌溶液
    储存条件Stroe at -20℃,6 months.
    靶点HDAC (Histone deacetylases)
    通路DNA Damage/DNA Repair;Epigenetics;NF-κB
    背景说明Panobinostat是一种非选择性组蛋白去乙酰化酶 (HDAC) 抑制剂。
    生物活性Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities. Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells. Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma.[1-5]
    In VitroPanobinosta (LBH589) induces apoptosis of both MOLT-4 and Reh cells in a time- and dose-dependent manner. Panobinosta treatment results in histone (H3K9 and H4K8) hyperacetylation and regulation of cell-cycle control genes in Reh cells[1]. Panobinostat exhibites potent antiproliferative activity in human NSCLC cell lines with the IC50 ranging from 5 to 100 nM[2].Panobinostat
    细胞实验Panobinosta (10, 20 mg/kg, i.p.) significantly slows tumor growth derived from Meso and NSCLC cells in vivo models. Panobinosta markedly increases acetylation of histone H3 and H4 of H69 human SCLC cells harvest from SCID mice[2]. Panobinostat (5, 10 and 20 mg/kg i.p.) demonstrates a clear benefit of decreased tumor burden, significantly improves TTE and reduces bone density loss in a disseminated multiple myeloma mouse model[3].
    细胞实验Cells are washed with ice-cold PBS containing 0.1 mM sodium orthovanadate, and total proteins are isolated using RIPA lysis buffer, which includes protease inhibitors (leupeptin, antipain, and aprotinin), 0.5 mM PMSF, and 0.2 mM sodium orthovanadate. Protein amounts are quantified using the Bio-Rad protein assay. Equal amounts of proteins are loaded onto an sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel, transferred onto nitrocellulose membrane, and probed with the antibody of interest: mouse monoclonal c-Myc and mouse monoclonal p21 antibodies; rabbit polyclonal phospho-Histone H2A.X, rabbit polyclonal acetyl-Histone H3 (Lys9), and rabbit polyclonal acetyl-Histone H4 (Lys8) antibodies; mouse monoclonal p27/KIP1 antibody; mouse monoclonal anti-β-actin; and mouse monoclonal anti-GADD45G. Membranes are then washed, reprobed with appropriate horseradish peroxidase-conjugated secondary antibodies, and developed with SuperSignal chemiluminescent substrate.[1-5]
    动物实验AE17 and TC-1 cancer cells (1×106 cells) are injected into the flanks of adult female C57Bl/6 mice and severe combined immunodeficiency (SCID) mice. M30 (10×106 cells), A549 (5×106 cells), H69 (2.5×106 cells), BK-T (6.5×106), H526 (10×106), and RG1 (10×106) cells are also injected, but in the presence of matrigel, into the flanks of SCID mice. When tumors reach 100 to 500 mm3, panobinostat is administered via i.p. injections (10-20 mg/kg) on a daily schedule (5-days-on, 2-days-off regimen) for the entire duration of the experiment. Control micereceive i.p. injections with dextrose 5% in water. Every tumor is measured with a caliper at least twice weekly. For evaluation of the effects of combination therapy on SCLC-derived tumors, SCID mice with H69 tumors are administered panobinostat. Three days after the initiation of panobinostat, and again 1 wk later, etoposide (40 mg/kg) is administered i.p.[1-5]
    数据来源文献[1]. Scuto A, et al. The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells. Blood. 2008 May 15;111(10):5093-100.
    [2]. Crisanti MC, et al. The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Mol Cancer Ther. 2009 Aug;8(8):2221-31.
    [3]. Ocio EM, et al. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma. Haematologica. 2010 May;95(5):794-803.
    [4]. Banerjee NS, et al. Vorinostat, a?pan-HDAC?inhibitor,?abrogates?productive?HPV-18?DNA?amplification. Proc Natl Acad Sci U S A.?2018 Nov 20;115(47):E11138-E11147.
    [5]. Barton K, et al. Broad activation of latent HIV-1 in vivo. Nat Commun. 2016;7:12731. Published 2016 Sep 8.
    单位

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 【求助】cAMP的测定

      含量成反比。 本试剂盒用于检测在GPCR激动剂刺激下活细胞或者细胞膜制备品产生的cAMP。对于偶联Gαs的受体,激动剂刺激导致665nm的荧光强度降低,而拮抗剂则可以逆转这一效应;对于偶联Gαi的受体,在激动剂刺激的同时用forskolin刺激cAMP产生,那么激动剂则抑制forskolin诱导的cAMP的生成,因此对照只给forskolin的细胞组可以通过665nm荧光强度的增加反应激动剂的效应。 该试剂盒的灵敏度很高,室温下反应在20h内是稳定的。本试剂

    • 【原创】组织免疫共沉淀的实验方法

      1将有利于提取染色质蛋白1% SDS5 mM EDTA室温可保存1周使用前加入:Protease inhibitors、10mM DTT or beta-mercaptoethanol、15 U/ml DNase15、其它所需试剂:蛋白酶抑制剂Protease inhibitors :推荐使用蛋白酶抑制剂cocktail,也可使用PMSF (50 ug/ml)和aprotinin (1 ug/ml).无菌PBS pH 7.4无菌PBS-BSA 1% (过滤处理)TBST缓冲液WB上样buffer

    • In vivo dual cross-linking chromatin immunoprecipitation: detecting chromatin proteins not directly bound to DNA

      % ethanol; Vortex and precipitate at -80°C for 40 minutes; Centrifuge at 14000 rpm for 30 minutes at 4°C; Remove the supernatant and wash pellet with 200µl of cold 70% ethanol; Resuspend IP-DNA and INPUT samples in 50-100µl 10mM

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥540
    北京索莱宝科技有限公司
    2025年07月10日询价
    ¥1720
    上海研卉生物科技有限公司
    2025年10月16日询价
    询价
    北京诺博莱德科技有限公司
    2025年11月19日询价
    询价
    上海雅心生物技术有限公司
    2026年01月20日询价
    ¥135
    翌圣生物科技(上海)股份有限公司
    2025年10月19日询价
    IP12901 帕比司他(10mM in DMSO,无菌) 抑制剂/拮抗剂/激动剂 索莱宝
    ¥640